Resverlogix Announces Publication of Key Apabetalone Study BETonMACE in the Journal of the American Medical Association

NEXT STORY
PhaseBio Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Recent Business Highlights
PREV STORY
Rhythm Pharmaceuticals Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Setmelanotide in POMC and LEPR Deficiency Obesities
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Idera Pharmaceuticals Announces Acceptance of Several Abstracts related to the ILLUMINATE Tilsotolimod Clinical Development Program at the American Society of Clinical Oncology (ASCO) Meeting

author_avatar
NASDAQ Market News

The Global Antimicrobial Susceptibility Testing Market is expected to grow by $ 936.87 mn during 2021-2025, progressing at a CAGR of over 5% during the forecast period

author_avatar
NASDAQ Market News

MatriSys Bioscience announces successful FDA Pre-IND review and Phase 2 plans for MSB-01, a revolutionary human-microbiome based treatment for Atopic Dermatitis

author_avatar
NASDAQ Market News